As the U.S. Food and Drug Administration prepares for the mass return of its workforce, officials have warned of significant logistical hurdles, notably inadequate workspace and parking. This comes amid broader federal efforts to curtail remote work and downsize agency operations, which have sparked concerns among staff members.
About the Author
